性休克患者的辅助血管压缩剂:系统审查和元分析的协议
Seth R Bauer1,2, Patrick M Wieruszewski3,4, Brittany D Bissell5
1Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
辅助血管压缩剂经常在败血症休克中使用,尽管益处不明确. 本系统性审查综合了关于其在成年患者中的有效性和安全性的直接证据,以告知临床实践.
科学领域:
- 临界护理医学 临界护理医学
- 药理学 药理学是指药理学的学科.
- 基于证据的医学基于证据的医学.
背景情况:
- 超过三分之一的败血性休克患者接受辅助血管压缩剂.
- 没有任何随机试验证实使用它们可以改善死亡率.
- 之前的系统性审查存在限制,阻碍了解释.
结论:
- 这项严格的审查旨在澄清辅助血管压缩剂对患者重要结果的影响.
- 调查结果将为临床实践和治疗指南提供信息,用于感染性休克管理.
- 在PROSPERO注册的研究 (CRD4202327984).
更多相关视频
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
Heart Failure VI: Adjunct Therapies
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiopulmonary Resuscitation IV: Pharmacological Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
